Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 06, 2023

SELL
$5.8 - $8.98 $169,035 - $261,713
-29,144 Reduced 60.18%
19,287 $125,000
Q1 2022

May 10, 2022

SELL
$13.42 - $23.38 $180,874 - $315,115
-13,478 Reduced 21.77%
48,431 $671,000
Q4 2021

Feb 10, 2022

BUY
$12.78 - $23.74 $195,725 - $363,578
15,315 Added 32.87%
61,909 $1.47 Million
Q2 2021

Aug 11, 2021

SELL
$12.85 - $16.2 $43,702 - $55,096
-3,401 Reduced 6.8%
46,594 $652,000
Q4 2020

Feb 16, 2021

BUY
$12.4 - $17.6 $330,323 - $468,846
26,639 Added 114.06%
49,995 $757,000
Q3 2020

Nov 10, 2020

BUY
$11.59 - $14.93 $270,696 - $348,705
23,356 New
23,356 $309,000

Others Institutions Holding MGTX

About MeiraGTx Holdings plc


  • Ticker MGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,010,700
  • Market Cap $192M
  • Description
  • MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative dise...
More about MGTX
Track This Portfolio

Track Td Asset Management Inc Portfolio

Follow Td Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.